Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 5

Research Article

Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study

Table 5

Taking lipid-lowering drugs, n (%).

C-117 formula group (n=59)Placebo group (n=59)

Atorvastatin calcium tablets (Lipitor)44(74.6%)42(71.2%)
Other lipid-lowering drugs7(11.9%)9(15.3%)
Not taken or the lipid-lowering medication time < 20% of the 6-month treatment8(13.5%)8(13.5%)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.